/ /

Lynda Charters
Managing viral eye infection: What clinicians should know
Though much research is happening in the diagnosis and treatment of viral eye infections, much of it might not be readily apparent to clinicians, explains Todd P. Margolis, MD, PhD.
Transzonular intravitreal injection eases treatment burden after cataract surgery
Transzonular intravitreal injection eases treatment burden after cataract surgery
An intraoperative injection of a compounded formulation of triamcinolone acetonide, moxifloxacin, and vancomycin eliminated the need for supplemental postoperative medications in the vast majority of patients who underwent phacoemulsification and IOL implantation.
Intracameral phenylephrine/ketorolac superior to intracameral epinephrine
Phenylephrine 1%/ketorolac injection 0.3% added to ophthalmic irrigation solution and administered intracamerally during cataract surgery was associated with a statistically significant reduction in surgical time, intraoperative complications, and use of pupil dilating devices and with a statistically significant improvement in best-corrected visual acuity.
How to manage retinal disease in pregnant patients
How to manage retinal disease in pregnant patients
Pregnant patients require special care and surveillance when retinal diseases are present.
Paradigm shifting for ILM peeling, prone position after vitrectomy
Peeling of the internal limiting membrane has increasingly become a dogma of surgical retina, while maintenance of the face-down positioning may become anachronistic in many cases.
Tips for successful surgery with secondary IOLs
Aphakic eyes that have no or inadequate capsular support can pose a significant challenge to cataract surgeons. Careful attention to the preoperative considerations, appropriate intraocular lens choices, surgical techniques, and postoperative management can ensure optimal results.
Tracking treatment adherence in newly diagnosed open-angle glaucoma
Tracking treatment adherence in newly diagnosed open-angle glaucoma
An analysis of U.S. claims data reveals a substantial proportion of patients (17%) remained untreated 4 years after their initial diagnosis of open-angle glaucoma.
Lower treatment burden with aflibercept for CRVOs
Cystoid macular edema (CME) might become less problematic in patients with non-ischemic central retinal vein occlusions (CRVOs).
New study affirms promise of anti-integrin drug for DME
New study affirms promise of anti-integrin drug for DME
A new class of ophthalmic drug continues to show promise for treating patients with diabetic macular edema (DME).